Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is 4169,04 zł, with a 24-hour trading volume of 8,11B zł. The asset's market cap is 3,71T zł, after moving -2.41% in the last day.
Tokenized Eli Lilly And Co is trading at 4187,02 zł, with a tokenized market cap of 161,23M zł and a 24-hour trading volume of 9,54M zł. The tokenized asset has moved -0.60% in the past 24 hours.